Enterprise
Mankind Pharma Q2 profit jumps 29%; chronic segment outperforms
The company reported a stronger-than-expected profit, driven by high demand for its drugs for chronic conditions such as diabetes and cardiovascular diseases.
Titan MD attributes 'depressed Q2 profitability' to customs duty losses, growth investments
After recording a 25% fall in net profit for Q2 FY25, MD Venkat says the company is confident about its performance for the rest of the financial year
Apollo Green Energy plans IPO by 2025; aims to achieve ₹10,000 cr portfolio by next year
The renewable energy arm of Apollo International Group currently manages an order book of ₹3,500 crore across solar and hydro energy.
Embassy REIT CEO Aravind Maiya steps down after SEBI action
Embassy REIT announced CEO Maiya's resignation after SEBI issued a show-cause notice citing his disqualification following a 10-year audit ban. Maiya will now serve as Head of Strategy for the REIT
Enterprise
Mankind Pharma Q2 profit jumps 29%; chronic segment outperforms
The company reported a stronger-than-expected profit, driven by high demand for its drugs for chronic conditions such as diabetes and cardiovascular diseases.
Titan MD attributes 'depressed Q2 profitability' to customs duty losses, growth investments
After recording a 25% fall in net profit for Q2 FY25, MD Venkat says the company is confident about its performance for the rest of the financial year
Apollo Green Energy plans IPO by 2025; aims to achieve ₹10,000 cr portfolio by next year
The renewable energy arm of Apollo International Group currently manages an order book of ₹3,500 crore across solar and hydro energy.
Embassy REIT CEO Aravind Maiya steps down after SEBI action
Embassy REIT announced CEO Maiya's resignation after SEBI issued a show-cause notice citing his disqualification following a 10-year audit ban. Maiya will now serve as Head of Strategy for the REIT